Literature DB >> 21385017

Storage-induced increase in biomarkers of oxidative stress and inflammation in red blood cell components.

Bülent Kücükakin1, Volkan Kocak, Jens Lykkesfeldt, Hans J Nielsen, Karin Magnussen, Jacob Rosenberg, Ismail Gögenur.   

Abstract

BACKGROUND: Transfusion of blood components may increase the risk of complications in relation to surgery. During storage, red blood cells (RBCs) undergo structural and functional changes that may reduce function and viability after transfusion. The aim of the study was to evaluate the quality of buffy-coat reduced red cells in SAG-M additive solution, by assessing biomarkers of oxidative and inflammatory stress during a storage period of 35 days. STUDY DESIGN AND METHODS: Ten units of RBCs were stored for 35 days. Samples were collected from the units at storage days 1, 3, 7, 14, 21, 28 and 35, respectively. The samples were analysed for various biomarkers expressing the oxidative stress and inflammation, including malondialdehyde (MDA), α-tocopherol (AT), dehydroascorbic acid (DHA), ascorbate (ASC), YKL-40 and interleukin-6 (IL-6).
RESULTS: The levels ofMDA, ASC, DHA, IL-6 and YKL-40 changed significantly during the storage period (p < 0.001, p < 0.001, p < 0.001, p = 0.004 and p < 0.001 respectively). A significant change in AT levels could not be shown (p = 0.087).
CONCLUSIONS: RBCs displayed significant changes in all measured indices of oxidative and inflammatory stress during a storage period of 35 days except for AT. The data suggest a possible rationale behind the observation that aging blood products may increase the risk of complications following surgery and blood transfusion.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21385017     DOI: 10.3109/00365513.2011.563789

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  7 in total

1.  Inability to maintain GSH pool in G6PD-deficient red cells causes futile AMPK activation and irreversible metabolic disturbance.

Authors:  Hsiang-Yu Tang; Hung-Yao Ho; Pei-Ru Wu; Shih-Hsiang Chen; Frans A Kuypers; Mei-Ling Cheng; Daniel Tsun-Yee Chiu
Journal:  Antioxid Redox Signal       Date:  2015-02-10       Impact factor: 8.401

2.  l-carnitine as a Potential Additive in Blood Storage Solutions: A Study on Erythrocytes.

Authors:  R Soumya; H Carl; R Vani
Journal:  Indian J Hematol Blood Transfus       Date:  2015-07-11       Impact factor: 0.900

3.  Transfusion of red blood cells stored for shorter versus longer duration for all conditions.

Authors:  Akshay Shah; Susan J Brunskill; Michael Jr Desborough; Carolyn Doree; Marialena Trivella; Simon J Stanworth
Journal:  Cochrane Database Syst Rev       Date:  2018-12-22

4.  Protective Effect of Selenium-Based Medicines on Toxicity of Three Common Organophosphorus Compounds in Human Erythrocytes In Vitro.

Authors:  Maryam Sadat Fakhri-Bafghi; Seyedeh Farnaz Ghasemi-Niri; Sara Mostafalou; Mona Navaei-Nigjeh; Maryam Baeeri; Azadeh Mohammadirad; Mohammad Abdollahi
Journal:  Cell J       Date:  2016-01-17       Impact factor: 2.479

5.  Prospects of Vitamin C as an Additive in Plasma of Stored Blood.

Authors:  R Vani; R Soumya; H Carl; V A Chandni; K Neha; B Pankhuri; S Trishna; D P Vatsal
Journal:  Adv Hematol       Date:  2015-08-09

6.  N-acetylcysteine Restored Heart Rate Variability and Prevented Serious Adverse Events in Transfusion-dependent Thalassemia Patients: a Double-blind Single Center Randomized Controlled Trial.

Authors:  Sintip Pattanakuhar; Arintaya Phrommintikul; Adisak Tantiworawit; Somdet Srichairattanakool; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  Int J Med Sci       Date:  2020-05-18       Impact factor: 3.738

7.  Correcting glucose-6-phosphate dehydrogenase deficiency with a small-molecule activator.

Authors:  Sunhee Hwang; Karen Mruk; Simin Rahighi; Andrew G Raub; Che-Hong Chen; Lisa E Dorn; Naoki Horikoshi; Soichi Wakatsuki; James K Chen; Daria Mochly-Rosen
Journal:  Nat Commun       Date:  2018-10-02       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.